Look behind the lecture: exploiting RNA as a drug target
In this interview, Elliot Nickbarg (MSD Research Laboratories; NJ, USA) discusses his upcoming presentation at the Targeting RNA Congress (Frankfurt, Germany; 26–27 November 2019) on the current landscape of RNA-targeting therapeutics, as well as some of the work being done to advance this field.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>